Skip to main content

Articles

Page 6 of 7

  1. Chemotherapeutic agents have limited efficacy and resistance to them limits today and will limit tomorrow our capabilities of cure. Resistance to treatment with anticancer drugs results from a variety of facto...

    Authors: Eudald Casals, Muriel F. Gusta, Macarena Cobaleda-Siles, Ana Garcia-Sanz and Victor F. Puntes
    Citation: Cancer Nanotechnology 2017 8:7
  2. Nanoparticles (NPs) have been shown to have good ability to improve the targeting and delivery of therapeutics. In the field of photodynamic therapy (PDT), this targeting advantage of NPs could help ensure dru...

    Authors: Zahraa Youssef, Régis Vanderesse, Ludovic Colombeau, Francis Baros, Thibault Roques-Carmes, Céline Frochot, Habibah Wahab, Joumana Toufaily, Tayssir Hamieh, Samir Acherar and Amirah Mohd Gazzali
    Citation: Cancer Nanotechnology 2017 8:6
  3. Early diagnosis, monitoring and treatment selection of cancer represent major challenges in medicine. The definition of the complex clinical and molecular landscape of cancer requires the combination of multip...

    Authors: Luca Guerrini, Nicolas Pazos-Perez, Eduardo Garcia-Rico and Ramon Alvarez-Puebla
    Citation: Cancer Nanotechnology 2017 8:5
  4. Small metallic nanoparticles are proposed as potential nanodrugs to optimize the performances of radiotherapy. This strategy, based on the enrichment of tumours with nanoparticles to amplify radiation effects ...

    Authors: Sha Li, Erika Porcel, Hynd Remita, Sergio Marco, Matthieu Réfrégiers, Murielle Dutertre, Fabrice Confalonieri and Sandrine Lacombe
    Citation: Cancer Nanotechnology 2017 8:4
  5. Over the past two decades, there has been a significant evolution in the technologies and techniques employed within the radiation oncology environment. Over the same period, extensive research into the use of...

    Authors: Raymond B. King, Stephen J. McMahon, Wendy B. Hyland, Suneil Jain, Karl T. Butterworth, Kevin M. Prise, Alan R. Hounsell and Conor K. McGarry
    Citation: Cancer Nanotechnology 2017 8:3
  6. There has been growing interest in the use of nanomaterials for a range of biomedical applications over the last number of years. In particular, gold nanoparticles (GNPs) possess a number of unique properties...

    Authors: Soraia Rosa, Chris Connolly, Giuseppe Schettino, Karl T. Butterworth and Kevin M. Prise
    Citation: Cancer Nanotechnology 2017 8:2
  7. Radiotherapy has been an integral treatment modality for cancer. The field arose from and progressed through innovations in physics, engineering, and biology. The evolution of radiation oncology will rely on t...

    Authors: Yu Mi, Zhiying Shao, Johnny Vang, Orit Kaidar-Person and Andrew Z. Wang
    Citation: Cancer Nanotechnology 2016 7:11
  8. Cancer is first and foremost a disease of the genome. Specific genetic signatures within a tumour are prognostic of disease outcome, reflect subclonal architecture and intratumour heterogeneity, inform treatme...

    Authors: Harry W. Clifford, Amy P. Cassidy, Courtney Vaughn, Evaline S. Tsai, Bianka Seres, Nirmesh Patel, Hannah L. O’Neill, Emil Hewage and John W. Cassidy
    Citation: Cancer Nanotechnology 2016 7:10
  9. Radiotherapy is currently used in around 50% of cancer treatments and relies on the deposition of energy directly into tumour tissue. Although it is generally effective, some of the deposited energy can advers...

    Authors: Kaspar Haume, Soraia Rosa, Sophie Grellet, Małgorzata A. Śmiałek, Karl T. Butterworth, Andrey V. Solov’yov, Kevin M. Prise, Jon Golding and Nigel J. Mason
    Citation: Cancer Nanotechnology 2016 7:8
  10. Poor biodistribution and accumulation of chemotherapeutics in tumors due to limitations on diffusive transport and high intra-tumoral pressures (Jain RK, Nat Med. 7(9):987–989, 2001) have prompted the investigati...

    Authors: Norman A. Lapin, Martyna Krzykawska-Serda, Matthew J. Ware, Steven A. Curley and Stuart J. Corr
    Citation: Cancer Nanotechnology 2016 7:5
  11. Despite being one of the most common cancers, bladder cancer is largely inefficiently and inaccurately staged and monitored. Current imaging methods detect cancer only when it has reached “visible” size and ha...

    Authors: Sean K Sweeney, Yi Luo, Michael A O’Donnell and Jose Assouline
    Citation: Cancer Nanotechnology 2016 7:3
  12. Functionalized gold nanoparticles are emerging as a promising nanocarrier for target specific delivery of the therapeutic molecules in a cancer cell, as a result it targeted selectively to the cancer cell and ...

    Authors: Sushma Kalmodia, Suryanarayanan Vandhana, B. R. Tejaswini Rama, Balasubramanyam Jayashree, T. Sreenivasan Seethalakshmi, Vetrivel Umashankar, Wenrong Yang, Colin J. Barrow, Subramanian Krishnakumar and Sailaja V. Elchuri
    Citation: Cancer Nanotechnology 2016 7:1
  13. AGuIX are gadolinium-based nanoparticles developed mainly for imaging due to their MR contrast properties. They also have a potential role in radiation therapy as a radiosensitizer. We used MRI to quantify the...

    Authors: Alexandre Detappe, Sijumon Kunjachan, Joerg Rottmann, James Robar, Panagiotis Tsiamas, Houari Korideck, Olivier Tillement and Ross Berbeco
    Citation: Cancer Nanotechnology 2015 6:4
  14. Five year survival for metastatic melanoma (MM) is very low at <10%. Therapeutic options have been limited secondary to systemic toxicity. As a result there has been a growing movement towards developing targe...

    Authors: Sameer Kaiser, Maximilian B MacPherson, Ted A James, Albert Emery, Page Spiess, Albert van der Vliet, Christopher C Landry and Arti Shukla
    Citation: Cancer Nanotechnology 2015 6:1
  15. Encapsulation of drugs in nanoparticles can enhance the accumulation of drugs in tumours, reduce toxicity toward healthy tissue, and improve pharmacokinetics compared to administration of free drug. To achieve...

    Authors: Sofie Snipstad, Sara Westrøm, Yrr Mørch, Mercy Afadzi, Andreas KO Åslund and Catharina de Lange Davies
    Citation: Cancer Nanotechnology 2014 5:8

    The Erratum to this article has been published in Cancer Nanotechnology 2015 6:3

  16. Recently, the addition of nanoparticles (NPs) has been proposed as a new strategy to enhance the effect of radiotherapy particularly in the treatment of aggressive tumors such as glioblastoma. The physical pro...

    Authors: Lenka Štefančíková, Erika Porcel, Pierre Eustache, Sha Li, Daniela Salado, Sergio Marco, Jean-Luc Guerquin-Kern, Matthieu Réfrégiers, Olivier Tillement, François Lux and Sandrine Lacombe
    Citation: Cancer Nanotechnology 2014 5:6
  17. Gold nanoparticles (GNPs), have been demonstrated as effective preclinical radiosensitising agents in a range of cell models and radiation sources. These studies have also highlighted difficulty in predicted c...

    Authors: Laura E Taggart, Stephen J McMahon, Fred J Currell, Kevin M Prise and Karl T Butterworth
    Citation: Cancer Nanotechnology 2014 5:5
  18. AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm...

    Authors: Géraldine Le Duc, Stéphane Roux, Amandine Paruta-Tuarez, Sandrine Dufort, Elke Brauer, Arthur Marais, Charles Truillet, Lucie Sancey, Pascal Perriat, François Lux and Olivier Tillement
    Citation: Cancer Nanotechnology 2014 5:4
  19. The possibility of developing novel contrast imaging agents for cancer cellular labelling and fluorescence imaging applications were explored using silica-coated cadmium selenide (CdSe) quantum dots (QDs). The...

    Authors: Muthunayagam Vibin, Ramachandran Vinayakan, Annie John, Francis Boniface Fernandez and Annie Abraham
    Citation: Cancer Nanotechnology 2014 5:1
  20. In this work matrix based nanoparticulate polymer systems have been designed using the diacrylate derivative of the well-known biocompatible polymer, poly(ethylene glycol) (PEG). This has been crosslinked usin...

    Authors: Dipti Kakkar Thukral, Shweta Dumoga, Shelly Arora, Krishna Chuttani and Anil K Mishra
    Citation: Cancer Nanotechnology 2014 5:3
  21. The aim of the present study was the direct covalent coupling of the epidermal growth factor receptor (EGFR)-specific monoclonal antibody (mAb) to the surface of poly(lactide)-co-glycolide (PLGA)-polyethylene ...

    Authors: Sahil Aggarwal, Swati Gupta, Dilrose Pabla and R. S. R. Murthy
    Citation: Cancer Nanotechnology 2013 4:46
  22. Green synthesis of silver nanoparticles was carried out using the aqueous extract of Alternanthera sessilis under various experimental conditions. The aqueous extract of Alternanthera sessilis showed significant ...

    Authors: M. Jannathul Firdhouse and P. Lalitha
    Citation: Cancer Nanotechnology 2013 4:45
  23. Cisplatin is used to treat a variety of tumors, but dose-limiting toxicities or intrinsic and acquired resistance limit its application in many types of cancer including breast. Cisplatin was attached to silic...

    Authors: Chandrababu Rejeeth, Tapas C. Nag and Soundarapandian Kannan
    Citation: Cancer Nanotechnology 2013 4:43
  24. A nanorobot is defined as any smart structure which is capable of actuation, sensing, manipulation, intelligence, and swarm behavior at the nanoscale. In this study, we designed an intelligent system using fuz...

    Authors: Mark Fletcher, Mohammad Biglarbegian and Suresh Neethirajan
    Citation: Cancer Nanotechnology 2013 4:44
  25. The aim of our study was to prepare multifunctional, biocompatible nanoparticles for site-specific drug delivery. Hydrophilic nanoparticles with surface-adorned amine, carboxyl, or aldehyde groups, to be later...

    Authors: Sourav Chattopadhyay, Sandeep Kumar Dash, Totan Ghosh, Debasis Das, Panchanan Pramanik and Somenath Roy
    Citation: Cancer Nanotechnology 2013 4:42
  26. As the nano revolution unfolds, it is imperative to integrate nanoscience and medicine. The secret gleaned from nature have led to the generation of biogenic technologies for the fabrication of advanced nanoma...

    Authors: Ravi Geetha, Thirunavukkarasu Ashokkumar, Selvaraj Tamilselvan, Kasivelu Govindaraju, Mohamed Sadiq and Ganesan Singaravelu
    Citation: Cancer Nanotechnology 2013 4:40
  27. Photothermal therapy (PTT) for cancer treatment is the use of heat between 41 and 45 °C to damage cancer cells. As a new type of transducer agent for PTT of cancer, CuS nanoparticles have several advantages. T...

    Authors: Chang Yang, Lun Ma, Xiaoju Zou, Guangya Xiang and Wei Chen
    Citation: Cancer Nanotechnology 2013 4:39
  28. Limited efficacy of current first-line treatment for leukemia calls attention for further development of efficient strategies. Recently, much attention has been given to nanoparticle-based drug delivery system...

    Authors: Tanmoy Bhowmik, Partha Pratim Saha, Anjan Dasgupta and Antony Gomes
    Citation: Cancer Nanotechnology 2013 4:36
  29. Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different ...

    Authors: Vahid Shirshahi, Fereshteh Shamsipour, Amir Hassan Zarnani, Javad Verdi and Reza Saber
    Citation: Cancer Nanotechnology 2013 4:35
  30. Intratumoral and intralesional administration of anticancer drugs in gels and implantable formulations is gaining much importance on account of its advantage of site-specific delivery with highly dependable fr...

    Authors: Tanya Vohra, Inderpreet Kaur, Hemraj Heer and Rayasa Ramachandra Murthy
    Citation: Cancer Nanotechnology 2013 4:32
  31. Urinary tract infection (UTI) is a predominant condition in prostate cancer patients. Escherichia coli ORN178 (EC-178) is the uropathogen that causes recurrent infection by binding specifically to adhesins of pro...

    Authors: Pallavi Vedantam, George Huang and T. R. Jeremy Tzeng
    Citation: Cancer Nanotechnology 2013 4:33
  32. As systemic cancer therapies improve and are able to control metastatic disease outside the central nervous system, the brain is increasingly the first site of relapse. The blood–brain barrier (BBB) represents...

    Authors: Mi-Ran Choi, Rizia Bardhan, Katie J. Stanton-Maxey, Sunil Badve, Harikrishna Nakshatri, Keith M. Stantz, Ning Cao, Naomi J. Halas and Susan E. Clare
    Citation: Cancer Nanotechnology 2012 3:29
  33. The development of smart nanoparticles that can exhibit the anti-cancer activity, introduces better efficacy and lower toxicity for treatment. The present study was aimed to evaluate the anti-cancer activity o...

    Authors: S. Chattopadhyay, S. P. Chakraborty, D. Laha, R. Baral, P. Pramanik and S. Roy
    Citation: Cancer Nanotechnology 2012 3:26

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.5
    5-year Journal Impact Factor: 5.1
    Source Normalized Impact per Paper (SNIP): 0.723
    SCImago Journal Rank (SJR): 0.671

    Speed 2023
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 93

    Usage 2023
    Downloads: 328,851
    Altmetric mentions: 109